Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Northwest Biotherapeutics, Inc. (NWBO) Starts Presentation at the Aegis Healthcare Conference

Northwest Biotherapeutics, Inc. is a development-stage biotechnology company engaging in the discovery, development and commercialization of immunotherapy products for treating cancers. The company’s DCVax uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company also develops DCVax-L, which is under Phase III clinical trials for glioblastoma multiforme brain cancer and ovarian cancer. For more information, visit the company’s website at

This entry was posted in Aegis Conference. Bookmark the permalink.

Comments are closed.